scholarly article | Q13442814 |
P819 | ADS bibcode | 1998PNAS...9511886R |
P356 | DOI | 10.1073/PNAS.95.20.11886 |
P932 | PMC publication ID | 21735 |
P698 | PubMed publication ID | 9751760 |
P5875 | ResearchGate publication ID | 13533746 |
P2093 | author name string | Sarkar DP | |
Hasnain SE | |||
Venkaiah B | |||
Ramani K | |||
Hassan Q | |||
P2860 | cites work | A 45,000-M(r) glycoprotein in the Sendai virus envelope triggers virus-cell fusion | Q27480846 |
Firefly luciferase gene: structure and expression in mammalian cells | Q29616519 | ||
Reconstituted viral envelopes--'Trojan horses' for drug delivery and gene therapy? | Q35287725 | ||
Targeted and nontargeted liposomes for in vivo transfer to rat liver cells of a plasmid containing the preproinsulin I gene | Q37508435 | ||
Tissue Targeting of Multivalent LeX-terminated N-Linked Oligosaccharides in Mice | Q38290387 | ||
F protein induced fusion of Sendai viral envelopes with mouse teratocarcinoma cells through Le(x)-Le(x) interaction | Q39463043 | ||
Biochemical and functional characterization of DNA complexes capable of targeting genes to hepatocytes via the asialoglycoprotein receptor | Q41120963 | ||
Long term correction of bilirubin-UDP-glucuronosyltransferase deficiency in Gunn rats by administration of a recombinant adenovirus during the neonatal period | Q41157449 | ||
Fusion-mediated microinjection of lysozyme into HepG2 cells through hemagglutinin neuraminidase-depleted Sendai virus envelopes. | Q41493721 | ||
Improved DNA: liposome complexes for increased systemic delivery and gene expression | Q41633695 | ||
How do viruses enter cells? The HIV coreceptors teach us a lesson of complexity | Q41670718 | ||
Bifunctionality of the AcMNPV homologous region sequence (hr1): enhancer and ori functions have different sequence requirements | Q42063806 | ||
In vivo gene transfer of insulin gene into neonatal rats by the HVJ-liposome method resulted in sustained transgene expression. | Q44402352 | ||
Gene therapy -- promises, problems and prospects | Q45883584 | ||
Novel gene delivery to liver cells using engineered virosomes | Q59443245 | ||
Incorporation of adenovirus into a ligand-based DNA carrier system results in retention of original receptor specificity and enhances targeted gene expression | Q64383560 | ||
Large-scale isolation of covalently closed circular DNA using gel filtration chromatography | Q70225483 | ||
Fate of DNA targeted to the liver by asialoglycoprotein receptor-mediated endocytosis in vivo. Prolonged persistence in cytoplasmic vesicles after partial hepatectomy | Q70722768 | ||
Isolation of detergent-extracted Sendai virus proteins by gel-filtration, ion-exchange and reversed-phase high-performance liquid chromatography and the effect on immunological activity | Q72397922 | ||
P433 | issue | 20 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 5 | |
P304 | page(s) | 11886-11890 | |
P577 | publication date | 1998-09-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Site-specific gene delivery in vivo through engineered Sendai viral envelopes | |
P478 | volume | 95 |
Q41948325 | A histidine switch in hemagglutinin-neuraminidase triggers paramyxovirus-cell membrane fusion |
Q38297491 | An internal segment (residues 58-119) of the hepatitis B virus X protein is sufficient to activate MAP kinase pathways in mouse liver |
Q40159983 | Cellular gene transfer mediated by influenza virosomes with encapsulated plasmid DNA. |
Q34084752 | Current status of pH-sensitive liposomes in drug delivery |
Q63246400 | Delivery technologies for cancer immunotherapy |
Q36293328 | Development of HVJ envelope vector and its application to gene therapy |
Q44631057 | Development of a Virosome Vaccine for Newcastle Disease Virus |
Q64093774 | Gene Therapy Leaves a Vicious Cycle |
Q34107177 | Gene therapy for dyslipidemia: clinical prospects |
Q40387559 | Histidylated lipid-modified Sendai viral envelopes mediate enhanced membrane fusion and potentiate targeted gene delivery |
Q42540967 | Inhibition of the interaction between NS3 protease and HCV IRES with a small peptide: a novel therapeutic strategy |
Q33870289 | Liver-directed gene therapy: promises, problems and prospects at the turn of the century |
Q34240331 | Long-term reduction of jaundice in Gunn rats by nonviral liver-targeted delivery of Sleeping Beauty transposon |
Q33804080 | Mucosal immunization with DNA vaccines |
Q39738109 | Reciprocal regulation of AKT and MAP kinase dictates virus-host cell fusion |
Q40885940 | Selective virus-mediated intracellular delivery of membrane-impermeant compounds by means of plasma membrane vesicles |
Q45325609 | Sendai virus recruits cellular villin to remodel actin cytoskeleton during fusion with hepatocytes |
Q33848045 | Sustained activation of mitogen-activated protein kinases and activator protein 1 by the hepatitis B virus X protein in mouse hepatocytes in vivo |
Q42816691 | Targeted cytosolic delivery of hydrogel nanoparticles into HepG2 cells through engineered Sendai viral envelopes. |
Q36552842 | Targeting ribosome assembly on the HCV RNA using a small RNA molecule |
Q33857121 | The potential of gene therapy in the treatment of hepatocellular carcinoma |
Q56057560 | Tools for translation: non-viral materials for therapeutic mRNA delivery |
Q34019880 | Virosomes: evolution of the liposome as a targeted drug delivery system |